Alexion Pharmaceuticals (NASDAQ:ALXN) reported 12/31/2018 earnings this Morning, coming in at $2.14 per share, beating Wall Street’s estimates of $1.82 per Share. Revenue for the quarter came in at $1.13 billion beating analyst estimates of $1.06 billion
Recent Trading for Alexion Pharmaceuticals (NASDAQ:ALXN)
Shares of Alexion Pharmaceuticals closed the previous trading session at with 129 shares trading hands.